Identification of hepatitis B virus integration in hepatitis C virus-infected hepatocellular carcinoma tissues

Journal of Hepatology

Volumn 26, Issue 4, 1997, Pages 771-778

  Urashima, Tetsuro ^a   Saigo, Kenichi ^a   Kobayashi, Susumu ^a   Imaseki, Hideo ^a   Matsubara, Hisahiro ^a   Koide, Yoshio ^a   Asano, Takehide ^a   Kondo, Yoichiro ^a   Koike, Katsuro ^b   Isono, Kaichi ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CANCER INSTITUTE   (Japan)

Author keywords

hepatitis B virus; hepatitis C virus; hepatocellular carcinoma; integration of HBV DNA; X region

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; DNA SEQUENCE; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; VIRUS INFECTION;

EID: 0030975606     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80241-3     Document Type: Article

References (34)

1. Beasley RP, Hwang LU, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. Lancet. ii:1981;1129-1133.
2. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
3. Colombo M, Kuo G, Choo QL, Donato MF, Ninno ED, Tommasini MA, Dioguard N, Houghton M. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet. ii:1989;1006-1008.
4. Ruiz J, Sangro B, Cuende JI, Beloqui O, Riezu-Boj JI, Herrero JI, Prieto J. Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology. 16:1992;637-641.
5. Hasan F, Jeffers LJ, Medina MD, Reddy KR, Parker T, Schiff ER, Houghton M, Choo QL, Kuo G. Hepatitis C-associated hepatocellular carcinoma. Hepatology. 12:1990;589-591.
6. Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-Tapias JM, Ventura M, Vall M, Bruguera M, Bru C, Castillo R, Rodes J. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet. ii:1989;1004-1006.
7. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi T, Watanabe Y, Koi S, Onji M, Ohta Y, Choo QL, Houghton M, Kuo G. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA. 87:1990;6547-6549.
8. Nishioka K, Watanabe J, Furuta S, Tanaka E, Iino S, Suzuki H, Tsuji T, Yano M, Kuo G, Choo QL, Houghton M, Oda T. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer. 67:1990;429-433.
9. Houghton M, Weiner A, Han J, Kuo G, Choo QL. Molecular biology of the hepatitis C virus: implications for diagnosis, development and control of viral disease. Hepatology. 14:1991;381-388.
10. Gerber MA. Relation of hepatitis C virus to hepatocellular carcinoma. J Hepatol. 17:1993;108-111.
11. Brechot C, Hadchouel M, Scotto J, Fonck M, Potet F, Vyas GN, Tiollais P. State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver disease. Proc Natl Acad Sci USA. 78:1981;3906-3910.
12. Shafritz DA, Shouval D, Sherman HI, Hadziyannis SJ, Kew MC. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. N Engl J Med. 305:1981;1067-1073.
13. Koike K, Kobayashi M, Yaginuma K, Shirakata Y. Structure and functions of integrated HBV DNA. Robinson W, Koike K, Will H. Hepadna Viruses. 1987;267-286 Alan R. Liss, New York.
14. Lai MY, Chen PJ, Yang PM, Sheu JC, Sung JL, Chen DS. Identification and characterization of intrahepatic hepatitis B virus DNA in HBsAg-seronegative patients with chronic liver disease and hepatocellular carcinoma in Taiwan. Hepatology. 12:1990;575-581.
15. Paterlini P, Driss F, Nalpas B, Pisi E, Franco D, Berthelot P, Brechot C. Persistence of hepatitis B and C viral genomes in liver cancer from HBsAg-negative patients: a study of a low-endemic area. Hepatology. 17:1992;20-29.
16. Brechot C, Pourcel C, Louise A, Rain B, Tiollais P. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature. 286:1980;533-535.
17. Nagaya T, Nakamura T, Tokino T, Tsurimoto T, Imai M, Mayumi T, Kamino K, Yamamura K, Matsubara K. The mode of hepatitis B virus DNA integration in chromosome of human hepatocellular carcinoma. Genes Devel. 1:1987;773-782.
18. Takada S, Gotoh Y, Hayashi S, Yoshida M, Koike K. Structural rearrangement of integrated hepatitis B virus DNA as well as cellular flanking DNA is present in chronically infected hepatic tissues. J Virol. 64:1990;822-828.
19. Spandau DF, Lee CH. trans-activation of viral enhancers by the hepatitis B virus X protein. J Virol. 62:1988;427-434.
20. Twu JS, Schloemer RH. Transcriptional trans-activating function of hepatitis B virus. J Virol. 61:1987;3448-3453.
21. Takada S, Koike K. Trans-activation function of 3′ truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues. Proc Natl Acad Sci USA. 87:1990;5628-5632.
22. Wollersheim M, Debelka U, Hofschneider PH. A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene. 3:1988;545-552.
23. Koike K, Shirakata Y, Yaginuma K, Arii M, Takada S, Nakamura I, Hayashi Y, Kawada M, Kobayashi M. Oncogenic potential of hepatitis B virus. Mol Biol Med. 6:1989;151-160.
24. Kekulé AS, Lauer U, Meyer M, Caselmann WH, Hofschneider PH, Koshy R. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature. 343:1990;457-461.
25. Caselmann WH, Meyer M, Kekulé AS, Lauer U, Hofschneider PH, Koshy R. A trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA. Proc Natl Acad Sci USA. 87:1990;2970-2974.
26. Schluter V, Meyer M, Hofschneider PH, Koshy R, Caselmann WH. Integrated hepatitis V virus X and 3′ truncated preS/S sequences derived from human hepatomas encode functionally active transactivators. Oncogene. 9:1994;3335-3344.
27. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. 1982;382-389 Cold Spring Harbor Laboratory, New York.
28. Kobayashi M, Koike K. Complete nucleotide sequence of hepatitis B virus DNA of subtype adr and its conserved gene organization. Gene. 30:1984;227-232.
29. Kohl NE, Legouy E, DePinho RA, Nisen PD, Smith RK, Gee CE, Frederick WA. Human N-myc is closely related in organization and nucleotide sequence to c-myc. Nature. 319:1986;73-77.
30. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
31. Okamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, Machida A, Mishiro S, Yoshizawa H, Miyakawa Y, Mayumi M. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from 5′-noncoding region. Jpn J Exp. 60:1990;215-222.
32. Kobayashi S, Hayashi H, Itoh Y, Asano T, Isono K. Detection of minus-strand hepatitis C virus RNA in tumor tissue of hepatocellular carcinoma. Cancer. 73:1994;48-52.
33. Paterlini P, Poussin K, Kew M, Franco D, Brechot C. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology. 21:1995;313-321.
34. Kim CM, Koike K, Saito I, Miyamura T, Jay G, HBx gene, of hepatitis B virus induces liver cancer in transgenic mice. Nature. 351:1991;317-320.